Publisher
Springer Science and Business Media LLC
Reference109 articles.
1. Glover RE, Knight GM, Chandler CIR. Antimicrobial resistance at the G7. BMJ. 2021;3(373):n1417. https://doi.org/10.1136/bmj.n1417.
2. G20 policy recommendations for advancing financial inclusion and productivity gains through digital public infrastructure. https://www.interaction.org/wp-content/uploads/2023/04/G20-Policy-Paper_2023.pdf
3. D’Atri F, Arthur J, Blix HS, Hicks LA, Plachouras D, Monnet DL, et al. Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries. Euro Surveill. 2019;24(28):1800339. https://doi.org/10.2807/1560-7917.ES.2019.24.28.1800339.
4. Schulz LT, Kim SY, Hartsell A, Rose WE. Antimicrobial stewardship during a time of rapid antimicrobial development: Potential impact on industry for future investment. Diagn Microbiol Infect Dis. 2019;95:114857.
5. Durand GA, Raoult D, Dubourg G, et al. Antibiotic discovery: history, methods and perspectives. Int J Antimicrob Agents. 2019;53(4):371–82. https://doi.org/10.1016/j.ijantimicag.2018.11.010.